|
GB0509965D0
|
|
Improved expression elements
|
|
GB0506642D0
|
|
Improved nitroreductase enzymes
|
|
GB0504587D0
|
|
Vectors comprising guinea pig CMV regulatory elements
|
|
GB0427222D0
|
|
Dextrin-containing composition for preventing adhesion
|
|
GB0420217D0
|
|
Enzyme-prodrug therapy for prosthetic joint repair
|
|
GB0419920D0
|
|
Buffered compositions
|
|
GB0411526D0
|
|
Conjugate
|
|
GB0405103D0
|
|
Enzyme-prodrug therapy for prosthetic joint repair
|
|
WO2004070041A1
|
|
Vectors for expression of toxins
|
|
WO2004064850A1
|
|
Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent
|
|
GB0320824D0
|
|
Improved expression elements
|
|
GB0312432D0
|
|
Vectors for expression of toxins
|
|
GB0308503D0
|
|
Improved expression elements
|
|
GB0302727D0
|
|
Vectors for expression of toxins
|
|
GB0302330D0
|
|
Improved expression elements
|
|
GB0301669D0
|
|
Composition
|
|
GB0301560D0
|
|
Composition
|
|
US2003153592A1
|
|
Method of treatment
|
|
CA2471300A1
|
|
Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
|
|
GB0228900D0
|
|
Cancer Immunotherapy
|
